GB1043859A - Novel phenanthrene derivatives and a process for the manufacture thereof - Google Patents

Novel phenanthrene derivatives and a process for the manufacture thereof

Info

Publication number
GB1043859A
GB1043859A GB9271/65A GB927165A GB1043859A GB 1043859 A GB1043859 A GB 1043859A GB 9271/65 A GB9271/65 A GB 9271/65A GB 927165 A GB927165 A GB 927165A GB 1043859 A GB1043859 A GB 1043859A
Authority
GB
United Kingdom
Prior art keywords
formula
compounds
atoms
ring
halide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB9271/65A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1043859A publication Critical patent/GB1043859A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novel compounds of the formula <FORM:1043859/C2/1> wherein R represents hydrogen, an alkyl, alkenyl or alkynyl group of up to 5 carbon atoms or an acyl group, and Z is a cyclo alkyl radical which includes a C3-C6 cyclo alkyl ring and contains at least 4C atoms where it partly consists of a cyclopropyl ring or at least 5C atoms where it partly consists of a cyclo butyl ring, are prepared by reacting compounds of the formula <FORM:1043859/C2/2> with an appropriate acid derivative such as a halide, anhydride or ester of a cycloalkane carboxylic acid and reducing the carbonyl group of the resulting morphinan of formula <FORM:1043859/C2/3> to a methylene group. Alternatively, the same compounds may be condensed with a halide of the formula Hal-CH2-Z. The product may be converted into an ether or ester and/or an acid addition salt. The end products may have a morphinan or isomorphinan structure and may be obtained as racemic mixtures or in optically active form of which the (-) forms are preferred. Pharmaceutical compositions having analgesic and antitussive activity and exhibiting an antagonistic action against the side effects of morphine contain as active ingredients compounds of the first above general formula. The compounds may be used in tablets, dragees, suppositories, capsules or in liquid form and may be used for enteral or parenteral application.
GB9271/65A 1964-03-05 1965-03-04 Novel phenanthrene derivatives and a process for the manufacture thereof Expired GB1043859A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH283764A CH446370A (en) 1964-03-05 1964-03-05 Process for the preparation of phenanthrene derivatives

Publications (1)

Publication Number Publication Date
GB1043859A true GB1043859A (en) 1966-09-28

Family

ID=4242707

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9271/65A Expired GB1043859A (en) 1964-03-05 1965-03-04 Novel phenanthrene derivatives and a process for the manufacture thereof

Country Status (7)

Country Link
BE (1) BE660533A (en)
CH (1) CH446370A (en)
DK (1) DK107485C (en)
ES (1) ES310125A1 (en)
FR (2) FR1428671A (en)
GB (1) GB1043859A (en)
NL (1) NL6502391A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184041A1 (en) * 1984-11-13 1986-06-11 Miles Inc. 6-Methylene morphinan purification technique
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2538075A1 (en) 1975-08-27 1977-03-17 Boehringer Sohn Ingelheim N-TETRAHYDROFURFURYL NOROXYMORPHONES, THEIR ACID ADDITIONAL SALTS, THE MEDICINAL PRODUCTS AND THE METHOD FOR THEIR MANUFACTURING

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184041A1 (en) * 1984-11-13 1986-06-11 Miles Inc. 6-Methylene morphinan purification technique
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists

Also Published As

Publication number Publication date
FR1428671A (en) 1966-02-18
NL6502391A (en) 1965-09-06
BE660533A (en) 1965-09-03
ES310125A1 (en) 1965-12-01
DK107485C (en) 1967-06-05
FR4249M (en) 1966-07-29
CH446370A (en) 1967-11-15

Similar Documents

Publication Publication Date Title
GB1062714A (en) -ß-(4&#39;-acyloxy-4&#39;-piperidyl)-ketones
GB1043859A (en) Novel phenanthrene derivatives and a process for the manufacture thereof
ES380859A1 (en) Dibenzo(d,g)(1,3)dioxocin-6-carboxylic acids, esters and salts
GB1396113A (en) Coated medicines and process for preparation of coated medicines
GB902659A (en) A process for the production of a derivative of thebaine
GB1314952A (en) 3,4,5-trialkoxy-benzoic acid derivatives and their uses
GB1038732A (en) Morphinan derivatives and a process for the manufacture thereof
GB843752A (en) Novel morphinane derivatives and a process for the manufacture thereof
GB971243A (en) Substituted 4-phenylaminoquinolines
JPS5640616A (en) Decarboxylation of carboxylic acids
JPS57144255A (en) Alpha-methylthio(1-alkyl-2-pyrrolyl)acetamide derivative
GB998355A (en) Phenylalanine derivatives
GB1018780A (en) Steroid (2,3í¬c) furazan compounds and the process for the production thereof
GB1108388A (en) 14-hydroxydihydronormorphinone derivatives
GB1300419A (en) New morphinone derivatives and their preparation
GB847779A (en) 2-(4-biphenylyl)-í¸-hexenoic acid esters thereof
ES338660A1 (en) 4-(2&#39;-tetrahydrofurfuryloxy carbonyl)-phenylamino-chloro-quinolines
JPS5772963A (en) Alpha-(2-pyridyl)arylacetaldehyde
GB1071304A (en) Novel substituted morphinans and a process for the manufacture thereof
GB1117456A (en) 1ªß-methyl-2,3ª‡-methylene steroids and a process for their manufacture
JPS5253839A (en) Preparation of 2-(2,2-dihalovinyl) cyclopropane crboxylic acids
GB843908A (en) Novel morphinan derivatives and the manufacture thereof
ES278797A1 (en) New uracil derivatives and process for their production
JPS5695197A (en) Aminobenzoic acid derivative and physiologically active agent containing the same
GB967890A (en) Improvements in antibiotics